New cases tested for RR-/MDR-TB in Libya

Libya: New cases tested for RR-/MDR-TB was 91.0% in 2023. ◆ Volatile

Latest (2023)
91.0%
Change on year
up 35.8%
World rank
91st
of 192 countries
All-time high
99.0%
in 2020
All-time low
0.1%
in 2007
Years of data
7
2005–2023

New cases tested for RR-/MDR-TB in Libya, 2005–2023

0204060801002005201420232005: 0.472007: 0.12008: 0.462019: 422020: 992021: 672023: 91

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for new cases tested for rr-/mdr-tb in Libya is 91.0%, measured in 2023.

That represents a change of up 35.8% on the previous year and up 19,682.6% over ten years.

Over the whole period, new cases tested for rr-/mdr-tb in Libya peaked at 99.0% in 2020 and was at its lowest, 0.1%, in 2007.

Libya ranks 91st of 192 countries on this measure, in the middle of the range.

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.3% 0.1% 0.5% 3
2010s 42.0% 42.0% 42.0% 1
2020s 85.7% 67.0% 99.0% 3

Countries ranked near Libya

  1. 91 Uruguay 91.0% compare
  2. 91 Netherlands 91.0% compare
  3. 91 United States 91.0% compare
  4. 91 China 91.0% compare
  5. 91 Myanmar 91.0% compare

See the full ranking of 204 places →

More health data for Libya

All data for Libya →

Frequently asked questions

What is new cases tested for rr-/mdr-tb in Libya?
New cases tested for rr-/mdr-tb in Libya was 91.0% in 2023, according to World Health Organization, Global Health Observatory.
What is the highest new cases tested for rr-/mdr-tb recorded in Libya?
The highest recorded value was 99.0% in 2020.
What is the lowest new cases tested for rr-/mdr-tb recorded in Libya?
The lowest recorded value was 0.1% in 2007.
How does Libya rank for new cases tested for rr-/mdr-tb?
Libya ranks 91st out of 192 countries with data for 2023.
Is new cases tested for rr-/mdr-tb rising or falling in Libya?
Over the last ten years it is up 19,682.6%. The long-run trend across the full record is volatile.
Where does this Libya data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 7 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
204 places, 3,368 data points, 2005–2024
Last refreshed